Emerging Infectious Disease ISSN: 1080-6059

Macrolide Resistance in Mycoplasma pneumoniae, Israel, 2010

Diana Averbuch, Carlos Hidalgo-Grass, Allon E. Moses, Dan Engelhard, and Ran Nir-Paz

Author affiliations: Author affiliation: Hadassah–Hebrew University Medical Center, Jerusalem, Israel

Figure 1

Time elapsed and chromatogram of wild-type Mycoplasma pneumonia strain M129 (ATCC 29342) compared with results from 5 samples from a 6-year-old boy in Israel. The A2063G mutation is shown to be evolving during treatment and predominates at the end.

Figure 1. Time elapsed and chromatogram of wild-type Mycoplasma pneumonia strain M129 (ATCC 29342) compared with results from 5 samples from a 6-year-old boy in Israel. The A2063G mutation is shown to be evolving during treatment and predominates at the end.

Main Article

¹These authors contributed equally to this article.

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.